Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines

Wnt pathway activation and ABCB1 expression account for attenuation of Proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells

(2015) Kowit Yu Chong et al.   CANCER BIOLOGY & THERAPY

Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway

(2015) Tsai-Hsien Hung et al.   Oncotarget

FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells

(2014) Tsai-Hsien Hung et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance

(2014) Yi-Jun Wang et al.   Cancers

Gene silencing of c-Met leads to brain metastasis inhibitory effects

(2013) Se Jeong Lee et al.   CLINICAL & EXPERIMENTAL METASTASIS

Mechanisms of Drug Resistance in Cancer Chemotherapy: Coordinated Role and Regulation of Efflux Transporters and Metabolizing Enzymes

(2013) Ramya Vadlapatla et al.   CURRENT PHARMACEUTICAL DESIGN

Inducible and constitutive HSP70s confer synergistic resistance against metabolic challenges

(2012) Kowit Yu Chong et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma

(2012) Yin Li et al.   JOURNAL OF SURGICAL ONCOLOGY

MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells

(2012) C.-T. Chen et al.   MOLECULAR CANCER THERAPEUTICS

Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cells

(2011) Petr Mlejnek et al.   ANNALS OF HEMATOLOGY

Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity

(2011) WENZHONG QUE et al.   APMIS

Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance

(2011) Z. Shi et al.   CANCER RESEARCH

Silencing of c-Met by RNA interference inhibits the survival, proliferation, and invasion of nasopharyngeal carcinoma cells

(2011) Yuncheng Li et al.   TUMOR BIOLOGY

Mechanisms of HGF/Met Signaling to Brk and Sam68 in Breast Cancer Progression

(2011) Alessia Locatelli et al.   Hormones & Cancer

In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs

(2011) Neelesh Sharma et al.   Therapeutic Advances in Medical Oncology

An overview of the c-MET signaling pathway

(2011) Shawna Leslie Organ et al.   Therapeutic Advances in Medical Oncology

Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib

(2010) A. Haouala et al.   BLOOD

Adenovirus-Mediated SiRNA Targeting c-Met Inhibits Proliferation and Invasion of Small-Cell Lung Cancer (SCLC) Cells

(2010) Zhao-Xia Wang et al.   JOURNAL OF SURGICAL RESEARCH

Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics

(2010) Anna Maria Calcagno et al.   JNCI-Journal of the National Cancer Institute

MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research

(2010) Weifeng Ke et al.   MEDICAL ONCOLOGY

Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line

(2009) Roberto Mazzanti et al.   BIOCHEMICAL PHARMACOLOGY

PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells

(2009) Hal E Crosswell et al.   BMC CANCER

Differential Regulation of Drug Transporter Expression by Hepatocyte Growth Factor in Primary Human Hepatocytes

(2009) M. Le Vee et al.   DRUG METABOLISM AND DISPOSITION

c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro

(2009) Sheng-Hua Chu et al.   JOURNAL OF NEURO-ONCOLOGY

Down-Regulation of c-Met Expression Inhibits Human HCC Cells Growth and Invasion by RNA Interference

(2009) Bin Xie et al.   JOURNAL OF SURGICAL RESEARCH

Targeting MET transcription as a therapeutic strategy in multiple myeloma

(2008) Cornel J. Phillip et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY